MEB 5.88% 1.8¢ medibio limited

Ametus Study

  1. 52 Posts.
    The Ametus study shows a potential of USD100m if MEB achieves 5% of the market in the US, with the first objective test for depression. Can use existing reimbursement codes so the route to market is simplified, and they have JHU to validate the science in the US. They just keep ticking boxes....
 
watchlist Created with Sketch. Add MEB (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
0.001(5.88%)
Mkt cap ! $4.308M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $1.841K 102.2K

Buyers (Bids)

No. Vol. Price($)
2 124937 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 197220 1
View Market Depth
Last update - 15.56pm 18/03/2019 (20 minute delay) ?
MEB (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.